Clinical trial · Observational
Surgery for Recurrent Intrahepatic Cholangiocarcinoma
Surgery for Recurrent Intrahepatic Cholangiocarcinoma: a Promise or an Excess?
NCT04072250CI-TRIAL-00040613completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators retrospectively reviewed the participants suffering from recurrent intrahepatic cholangiocarcinoma after curative resection and aimed to explore the predictive factors for recurrence and clarify the potential benefit of repeat hepatectomy or/with metastasectomy.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cholangiocarcinoma, Intrahepatic | Intrahepatic Cholangiocarcinoma | ONTOLOGY_EXACT | 0.98 |
| Recurrence Cholangiocarcinoma | Cholangiocarcinoma | PROBABILISTIC | 0.70 |
| Re-hepatectomy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| hepatectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Survival
- timeFrame
- 1977~2014
- description
- Including overall survival and disease free survival
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * R0 resection for intrahepatic cholangiocarcinoma at initial diagnosis. Exclusion Criteria: * (1)Patient with R1 or R2 resection * (2)Distant metastasis noted when laparotomy * (3)Surgical mortality
References
Publications (0)
Data not yet available
No reference posted for this study.